Evermore Global Advisors, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 89 filers reported holding ENZO BIOCHEM INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Evermore Global Advisors, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2021$6,126,000
+11.7%
1,730,6070.0%5.39%
+12.4%
Q2 2021$5,486,000
-38.8%
1,730,607
-33.6%
4.79%
-24.1%
Q1 2021$8,963,000
+36.5%
2,605,6070.0%6.32%
-11.1%
Q4 2020$6,566,000
+5.5%
2,605,607
-11.7%
7.10%
+25.9%
Q3 2020$6,225,000
-13.6%
2,950,204
-8.3%
5.64%
+59.0%
Q2 2020$7,205,000
-28.9%
3,216,704
-19.7%
3.55%
-14.1%
Q1 2020$10,140,000
-3.8%
4,007,8510.0%4.13%
+75.4%
Q4 2019$10,541,000
-26.9%
4,007,8510.0%2.35%
-32.4%
Q3 2019$14,428,000
+19.3%
4,007,851
+11.7%
3.48%
+52.8%
Q2 2019$12,089,000
-3.5%
3,587,251
-21.8%
2.28%
+15.6%
Q1 2019$12,521,000
-0.5%
4,586,419
+1.3%
1.97%
-4.5%
Q4 2018$12,587,000
-33.0%
4,527,819
-0.8%
2.06%
-14.0%
Q3 2018$18,797,000
-23.7%
4,562,304
-3.9%
2.40%
-21.7%
Q2 2018$24,642,000
-6.3%
4,747,904
-1.0%
3.07%
+9.1%
Q1 2018$26,293,000
-29.3%
4,797,904
+5.2%
2.81%
-51.8%
Q4 2017$37,187,000
-3.6%
4,562,775
+23.8%
5.84%
-2.0%
Q3 2017$38,587,000
-1.7%
3,685,520
+3.7%
5.96%
-40.2%
Q2 2017$39,250,000
+41.6%
3,555,233
+7.3%
9.97%
+93.0%
Q1 2017$27,728,000
+20.6%
3,312,7920.0%5.16%
+15.1%
Q4 2016$22,991,0003,312,7924.49%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2019
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders